Intravenous Thrombolytic Therapy in Acute Stroke: Frequent Systemic Problems and Solutions
One of the most important reasons why the use of the intravenous (IV) tissue plasminogen activator (tPA), which is one of the key elements of acute ischemic stroke treatment, is not sufficiently widespread is the fact that many common questions have not been adequately answered. In this review, ques...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2018-03-01
|
Series: | Türk Nöroloji Dergisi |
Subjects: | |
Online Access: | http://www.tjn.org.tr/jvi.aspx?pdir=tjn&plng=eng&un=TJN-01212 |